Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Core Laboratories Inc. /DE/CLB · Entity 5382 | CAO & Treasurer | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Core Laboratories Inc. /DE/
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,818.334 |
Reported balance
After 2026-10-01 transaction · row 1
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 99 · Balance 8,818.334 |
| Common StockSEC Table I · non-derivative | Direct | 8,917.334 |
Reported balance
After 2026-10-01 transaction · row 2
Sequence does not reconcile; account continuity is unresolved.
1 source rowRow 2 · 2026-10-01 · Exercise / conversion · Acquired 250 · Balance 8,917.334 |
| Restricted SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 6,000 |
Reported balance
After 2026-10-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-10-01 · Exercise / conversion · Disposed 250 · Balance 6,000 F1: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2: Multiple restricted share grants are included in this total. |
Filing footnotes · ownership attribution and instrument terms
F1: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date.
F2: Multiple restricted share grants are included in this total.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 5, 2026 16:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-413736 · ownership.xml · derivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 16:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-413736 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,917.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 16:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 99 | $9.76 | $966.24 |
DisclosureSEC source: 0001193125-26-413736 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,818.334 Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 14:36 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-331843 · ownership.xml · derivative · entry 6 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,490 Underlying: Common Stock · 200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 14:36 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 240 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-331843 · ownership.xml · derivative · entry 5 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,250 Underlying: Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 14:36 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-331843 · ownership.xml · nonDerivative · entry 4 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,625.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 14:36 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 90 | $10.64 | $957.60 |
DisclosureSEC source: 0001193125-26-331843 · ownership.xml · nonDerivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,535.334 Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 14:36 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-331843 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,775.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2026 Filed Aug 4, 2026 14:36 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 108 | $10.64 | $1,149.12 |
DisclosureSEC source: 0001193125-26-331843 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,667.334 Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 16:00 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | GrantPerformance Shares · Derivative | 7,526 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-053572 · ownership.xml · derivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,526 Underlying: Common Stock · 7,526 shares Expires not disclosed F1 · derivative.exercise_date: Assuming the recipient's continued employment (or death or disability while employed) and the satisfaction of certain performances criteria set forth below, this award will vest on December 31, 2028, following the conclusion of a three-year performance period that began on January 1, 2026 and ends on December 31, 2028 (the "Performance Period"). At the end of the Perofrmance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return on Invested Capital ("ROIC") among the Bloomberg Peer Group ("BPG"), and 200% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile of ROIC (equivalent to 100% up to 200% of the award). F1 · derivative.expiration_date: Assuming the recipient's continued employment (or death or disability while employed) and the satisfaction of certain performances criteria set forth below, this award will vest on December 31, 2028, following the conclusion of a three-year performance period that began on January 1, 2026 and ends on December 31, 2028 (the "Performance Period"). At the end of the Perofrmance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return on Invested Capital ("ROIC") among the Bloomberg Peer Group ("BPG"), and 200% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile of ROIC (equivalent to 100% up to 200% of the award). Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 00:35 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 864 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-305634 · ownership.xml · derivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,690 Underlying: Common Stock · 864 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 00:35 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 864 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-305634 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,765.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 00:35 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 340 | $15.39 | $5,232.60 |
DisclosureSEC source: 0001193125-25-305634 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,425.334 Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:15 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-228644 · ownership.xml · derivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,554 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:15 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-228644 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 21:15 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 99 | $12.58 | $1,245.42 |
DisclosureSEC source: 0001193125-25-228644 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,901.334 Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 13:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-102459 · ownership.xml · derivative · entry 6 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,004 Underlying: Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 13:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-102459 · ownership.xml · derivative · entry 5 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,804 Underlying: Common Stock · 200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 13:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-102459 · ownership.xml · nonDerivative · entry 4 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,748.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 13:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 108 | $10.53 | $1,137.24 |
DisclosureSEC source: 0000950170-25-102459 · ownership.xml · nonDerivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,640.334 Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 13:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-102459 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,840.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2025 Filed Aug 5, 2025 13:17 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 90 | $10.53 | $947.70 |
DisclosureSEC source: 0000950170-25-102459 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,750.334 Read SEC document |
| May 01, 2025 Filed May 5, 2025 18:55 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-063441 · ownership.xml · derivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,244 Underlying: Common Stock · 175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| May 01, 2025 Filed May 5, 2025 18:55 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-063441 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,587.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2025 Filed May 5, 2025 18:55 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 79 | $11.68 | $922.72 |
DisclosureSEC source: 0000950170-25-063441 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,508.334 Read SEC document |
| February 13, 2025 Filed Feb 13, 2025 21:45 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | GrantPerformance Shares · Derivative | 7,692 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-019977 · ownership.xml · derivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,692 Underlying: Common Stock · 7,692 shares Expires not disclosed F1 · derivative.exercise_date: Assuming the recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest on January 1, 2028, following the conclusion of a three-year performance period that began on January 1, 2025 and ends on December 31, 2027 (the "Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return on Invested Capital ("ROIC") among the Bloomberg Peer Group ("BPG"), and 200% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile of ROIC (equivalent to 100% up to 200% of the award). F1 · derivative.expiration_date: Assuming the recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest on January 1, 2028, following the conclusion of a three-year performance period that began on January 1, 2025 and ends on December 31, 2027 (the "Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return on Invested Capital ("ROIC") among the Bloomberg Peer Group ("BPG"), and 200% of the award will vest if the Company is at or above the 85th percentile of ROIC among the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile of ROIC (equivalent to 100% up to 200% of the award). Read SEC document |
| December 01, 2024 Filed Dec 2, 2024 21:19 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-132240 · ownership.xml · derivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,419 Underlying: Common Stock · 576 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| December 01, 2024 Filed Dec 2, 2024 21:19 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 576 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-132240 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,639.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2024 Filed Dec 2, 2024 21:19 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 227 | $20.42 | $4,635.34 |
DisclosureSEC source: 0000950170-24-132240 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,412.334 Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 18:13 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-112231 · ownership.xml · derivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,995 Underlying: Common Stock · 250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 18:13 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-112231 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,162.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 18:13 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 99 | $19.21 | $1,901.79 |
DisclosureSEC source: 0000950170-24-112231 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,063.334 Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · derivative · entry 9 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,685 Underlying: Common Stock · 80 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · derivative · entry 8 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,485 Underlying: Common Stock · 200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · derivative · entry 7 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,245 Underlying: Common Stock · 240 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · nonDerivative · entry 6 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,690.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 35 | $23.24 | $813.40 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · nonDerivative · entry 5 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,655.334 Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · nonDerivative · entry 4 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,855.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 90 | $23.24 | $2,091.60 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · nonDerivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,765.334 Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,005.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 17:05 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 93 | $23.24 | $2,161.32 |
DisclosureSEC source: 0000950170-24-090554 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,912.334 Read SEC document |
| May 01, 2024 Filed May 2, 2024 21:09 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionRestricted Shares · Derivative | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-052312 · ownership.xml · derivative · entry 3 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,765 Underlying: Common Stock · 175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| May 01, 2024 Filed May 2, 2024 21:09 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Exercise / conversionCommon Stock | 175 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-052312 · ownership.xml · nonDerivative · entry 2 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,689.334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2024 Filed May 2, 2024 21:09 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | Tax withholdingCommon Stock | 79 | $15.71 | $1,241.09 |
DisclosureSEC source: 0000950170-24-052312 · ownership.xml · nonDerivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,610.334 Read SEC document |
| April 09, 2024 Filed Apr 11, 2024 23:36 UTC | Core Laboratories Inc. /DE/ CLB · Entity 5382 | GrantPerformance Shares · Derivative | 6,662 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-043822 · ownership.xml · derivative · entry 1 Teo Sow Hang · CIK 0002017091 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,662 Underlying: Common Stock · 6,662 shares Expires not disclosed F1 · derivative.exercise_date: Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return On Invested Capital (ROIC) of the Bloomberg Peer Group (BPG), and 200% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile (equivalent to 100% up to 200% of the award). F1 · derivative.expiration_date: Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return On Invested Capital (ROIC) of the Bloomberg Peer Group (BPG), and 200% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile (equivalent to 100% up to 200% of the award). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.